Polaris Market Research today released findings from its latest report, projecting the global fertility supplements market to grow from USD 1,358.80 million in 2024 to USD 2,609.71 million by 2032, at a CAGR of 8.5%. The market was valued at USD 1,255.48 million in 2023. The report profiles 15 leading companies across five market segments.

Modern lifestyle factors, including high stress, sedentary habits, and delayed family planning, are contributing to rising fertility challenges worldwide. As a result, consumers are increasingly turning to supplements enriched with vitamins, minerals, and herbal extracts to support reproductive wellness alongside, or ahead of, medical interventions.

Analyst Commentary on Fertility Supplements Market Growth

"Rising infertility rates, delayed family planning, and growing awareness of nutrition's role in reproductive health are converging to drive demand for fertility supplements" said an analyst at Polaris Market Research. "Brands that lean into natural, clinically supported formulations are best positioned to capture the over-the-counter opportunity."

Fertility Supplements Market Statistics at a Glance

• 2024 Market Size: USD 1,358.80 Million
• 2032 Projected Size: USD 2,609.71 Million
• CAGR (2024-2032): 8.5%
• Largest Region (2023): Asia-Pacific

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: Increasing global prevalence of infertility, growing awareness of fertility and reproductive health, and a cultural shift toward natural, holistic wellness solutions are the primary forces behind the market's expansion, alongside rising demand for capsule-form supplements with proven ingredients such as folic acid and myo-inositol. In April 2025, Sanofi completed a USD 1 billion acquisition of the CoQ10 brand Qunol, expanding its consumer-health portfolio with fertility-related antioxidant products.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/fertility-supplements-market

Major Companies Covered: Vitabiotics Ltd., Orthomol, Fairhaven Health, Solaray, Babystart Ltd.

Segments Covered: By Ingredient (Natural, Synthetic, Blend of Natural and Synthetic), By Product, By End User, By Sales Channel, By Region.

The synthetic ingredient segment held a significant revenue share in 2023, valued for precise, consistent dosing and cost-effectiveness, while the capsules segment led by product form thanks to convenient dosing and optimal absorption. The women’s segment accounted for a significant share by end user, reflecting strong demand for supplements supporting hormonal balance and ovulatory health.

Additional Driver: Preference for Natural, Holistic Formulations: A growing share of consumers is favoring supplements built around natural ingredients over synthetic alternatives, reflecting a broader shift toward clean-label, sustainable health products. Manufacturers are responding with formulations that combine natural compounds, such as myo-inositol and herbal extracts, with a lower perceived risk of side effects than synthetic options.

Recent Developments in the Fertility Supplements Market

• April 2025: Sanofi completed its USD 1 billion acquisition of the CoQ10 brand Qunol, expanding its consumer-health portfolio with fertility-related antioxidant products.
• July 2023: Needed unveiled Sperm Support+, a product designed to help men optimize their contribution to successful conception.
• November 2022: Anglo French Drugs & Industries entered the fertility category with its LYBER Range, including LYBER-M and LYBER-PCO.

Regional Snapshot: Asia-Pacific Leads Growth, North America Holds Significant Share

Asia-Pacific is expected to register the strongest growth through the forecast period as fertility challenges, evolving lifestyles, and delayed family planning drive demand across China, India, and Japan. North America held a significant share of the market in 2023, supported by advanced healthcare infrastructure and heightened consumer awareness of reproductive wellness.

Market Outlook

Looking ahead, expanding awareness campaigns, increasing product innovation, and the growing normalization of proactive fertility care are expected to keep the fertility supplements market on a steady growth path through 2032, with over-the-counter and natural-ingredient formulations likely to capture a growing share of consumer spending.

Why It Matters for Fertility and Reproductive Wellness Product Investment

For stakeholders researching fertility and reproductive wellness product investment, the underlying report benchmarks fertility supplements market share, company positioning, and segment-level forecasts to support sourcing, partnership, and investment decisions through 2032. Beyond headline figures, the analysis is designed to help procurement teams, investors, and strategy leads translate market-size and growth-rate data into concrete sourcing, budgeting, and go-to-market decisions.

Report Coverage

The report offers detailed analysis of the fertility supplements market across ingredient, product, end user, sales channel, and region, along with competitive profiling of leading players, giving stakeholders a comprehensive view of where growth opportunities are emerging through 2032.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

how-ai-is-replacing-the-personal-trainer-inside-the-future-of-adaptive-fitness-coaching

digital-health-market

spring-market

neuromorphic-computing-market

how-bioluminescent-energy-solutions-are-enabling-a-sustainable-lighting-future

macarons-market

growth-factor-market

understanding-the-vital-role-of-plant-health-in-a-sustainable-future

automotive-plastics-market